Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267020
Status:
COMPLETED
Last Update Posted:
2020-08-31
First Post:
2005-12-16
Brief Title:
Phase 2 Study of Gemcitabine or Gemcitabine Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer
Sponsor:
Organization:
Eli Lilly and Company